Farm Comunitarios. 2022 Jan 11;14(1):6-15. doi: 10.33620/FC.2173-9218.(2022/Vol14).001.03

Impact of the professional pharmaceutical care service for smoking cessation in community pharmacies. Study protocol and characteristics of researchers and patients

Lage Piñón M1, Gómez Martínez JC2, Mendoza Barbero A3, Gaztelurrutia Lavesa L4, Plaza Zamora J5, Aguiló Juanola M6, Climent Catalá M7, de Andrés Dirube A8, García Moreno L9, Jaraiz Magariños I10, Moral Ajado M11, Sánchez Marcos N12
1. Grupo de Respiratorio y tabaquismo de la Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. Farmacéutica comunitaria en Culleredo (A Coruña). 2. Grupo de Respiratorio y tabaquismo de la Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. Farmacéutico comunitario en Barcelona (Barcelona). 3. Grupo de Respiratorio y tabaquismo de la Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. Farmacéutica comunitaria en Reus (Tarragona). 4. Grupo de Respiratorio y tabaquismo de la Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. Farmacéutica comunitaria en Barakaldo (Bizcaia). 5. Grupo de Respiratorio y tabaquismo de la Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. Farmacéutico comunitario en Mazarrón (Murcia). 6. Grupo de Respiratorio y tabaquismo de la Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. Farmacéutico comunitario en Palma (Illes Balears). 7. Farmacéutica comunitaria en L’Olleria (Valencia). 8. Farmacéutica comunitaria en Astillero (Cantabria). 9. Grupo de Respiratorio y tabaquismo de la Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. Farmacéutico comunitario en Munera (Albacete). 10. Farmacéutica comunitaria en Olloniego (Asturias). 11. Grupo de Respiratorio y tabaquismo de la Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. 12. Grupo de Respiratorio y tabaquismo de la Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. Farmacéutica comunitaria en San Sebastián de los Reyes (Madrid).
Lage M, Gómez JC, Mendoza A, Gaztelurrutia L, Plaza J, Aguiló M, Climent M, de A, García L, Jaraiz I, Moral M, Sánchez N. Impact of the professional pharmaceutical care service for smoking cessation in community pharmacies. Study protocol and characteristics of researchers and patients. Farm Comunitarios. 2022 Jan 11;14(1):6-15. doi: 10.33620/FC.2173-9218.(2022/Vol14).001.03
Abstract : 

Introduction: Smoking is a serious public health problem, 23% of Spanish adults aged over 15 smoke every day and 2.4% are occasional smokers. Community pharmacists (CP) are health professionals who are accessible and close to the population and can have an important role in smoking cessation. It is essential to conduct research studies that show the impact of CP intervention in smoking and help define an action protocol that can generally be implemented in any community pharmacy of our country.

Material and methods: The protocol was used in a prospective, placebo-controlled, non-randomized, 12-month follow-up study among smoking patients aged over 18 who came to the community pharmacy with a medical prescription to quit smoking, for a consultation to quit smoking or a patient identified as a smoker. The study was designed to be carried out in 100 pharmacies with pharmacists trained in the CESAR program (intervention group) who performed a structured intervention and in 100 pharmacies with untrained pharmacists (control pharmacies) who performed a habitual intervention. Each pharmacy had to enlist a total of 5 patients, which would involve a total of 1000 cases.

Results: 182 CPs participated in the study (intervention group: 102, control group: 80), most of whom practiced their profession in neighborhood pharmacies. The research involved 1,078 patients (intervention group: 800, control group: 278), with a homogeneous gender distribution and an average age of 49 years.

Article download link: 

Editor: © SEFAC. Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. 
Copyright© SEFAC. Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. This article is available from url https://www.farmaceuticoscomunitarios.org/. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-nd/4.0/

Share

-

Manual for authors

Journal Information